Analysis of Profitability Ratios
Quarterly Data
Beginner level
Profitability ratios measure the company’s ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Stryker Corp., profitability ratios (quarterly data)
Based on: 10-Q (filing date: 2020-07-31), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-06), 10-Q (filing date: 2019-10-30), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-24), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-22), 10-Q (filing date: 2016-04-22), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-10-23), 10-Q (filing date: 2015-07-29), 10-Q (filing date: 2015-04-30).
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Stryker Corp.’s gross profit margin ratio improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Stryker Corp.’s operating profit margin ratio improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Stryker Corp.’s net profit margin ratio improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Stryker Corp.’s ROE improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Stryker Corp.’s ROA improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
Gross Profit Margin
Stryker Corp., gross profit margin calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||
| Gross profit | 1,548 | 2,331 | 2,703 | 2,330 | 2,380 | 2,283 | 2,456 | 2,155 | 2,190 | 2,137 | 2,239 | 1,982 | 1,990 | 1,962 | 2,086 | 1,873 | 1,842 | 1,694 | 1,820 | 1,624 | 1,605 | 1,553 | |||||||
| Net sales | 2,764 | 3,588 | 4,131 | 3,587 | 3,650 | 3,516 | 3,796 | 3,242 | 3,322 | 3,241 | 3,471 | 3,006 | 3,012 | 2,955 | 3,157 | 2,833 | 2,840 | 2,495 | 2,715 | 2,420 | 2,432 | 2,379 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| Gross profit margin1 | 63.34% | 65.15% | 65.14% | 64.95% | 65.29% | 65.47% | 65.72% | 65.69% | 65.55% | 65.58% | 65.68% | 66.12% | 66.16% | 65.87% | 66.18% | 66.42% | 66.67% | 67.01% | 66.38% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| Gross Profit Margin, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 46.24% | 47.78% | 47.94% | 47.42% | 47.28% | 45.04% | 45.44% | 45.60% | 46.00% | 49.30% | 49.14% | 48.86% | 48.57% | 48.59% | 47.99% | 47.66% | 44.92% | 45.09% | 45.66% | 46.34% | 50.87% | 50.83% | |||||||
| Boston Scientific Corp. | 68.26% | 70.41% | 70.98% | 71.20% | 71.33% | 71.12% | 71.37% | 71.48% | 71.35% | 71.78% | 71.34% | 71.27% | 71.38% | 70.86% | 71.09% | 70.88% | 70.78% | 70.99% | 70.94% | — | — | — | |||||||
| Danaher Corp. | 55.28% | 55.85% | 55.74% | 55.61% | 55.53% | 55.71% | 55.83% | 56.03% | 56.18% | 55.80% | 55.61% | 55.27% | 55.09% | 55.36% | 55.29% | 54.16% | 53.47% | 52.86% | 52.34% | — | — | — | |||||||
| Intuitive Surgical Inc. | 67.07% | 69.04% | 69.45% | 69.45% | 69.47% | 69.60% | 69.92% | 70.07% | 70.22% | 70.31% | 70.12% | 69.75% | 69.97% | 70.08% | 69.89% | 69.42% | 68.38% | 67.28% | 66.18% | — | — | — | |||||||
| Medtronic PLC | 69.22% | 69.62% | 70.04% | 70.33% | 70.40% | 70.25% | 69.77% | 69.40% | 69.05% | 68.67% | 68.73% | 68.60% | 68.66% | 68.85% | 68.29% | 66.00% | 66.48% | 67.07% | 68.86% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 45.39% | 44.30% | 44.35% | 44.48% | 44.51% | 44.60% | 44.57% | 44.36% | 44.55% | 44.68% | 45.15% | 45.67% | 45.88% | 45.90% | 45.80% | 45.62% | 45.60% | 45.51% | 45.72% | — | — | — | |||||||
| UnitedHealth Group Inc. | 25.95% | 23.52% | 23.19% | 22.92% | 22.89% | 23.15% | 23.33% | 23.36% | 23.33% | 23.28% | 22.98% | 23.09% | 23.12% | 22.99% | 23.13% | 22.35% | 22.20% | 22.73% | 23.22% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-31), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-06), 10-Q (filing date: 2019-10-30), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-24), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-22), 10-Q (filing date: 2016-04-22), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-10-23), 10-Q (filing date: 2015-07-29), 10-Q (filing date: 2015-04-30).
1 Q2 2020 Calculation
Gross profit margin = 100
× (Gross profitQ2 2020
+ Gross profitQ1 2020
+ Gross profitQ4 2019
+ Gross profitQ3 2019)
÷ (Net salesQ2 2020
+ Net salesQ1 2020
+ Net salesQ4 2019
+ Net salesQ3 2019)
= 100 × (1,548 + 2,331 + 2,703 + 2,330)
÷ (2,764 + 3,588 + 4,131 + 3,587)
= 63.34%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Stryker Corp.’s gross profit margin ratio improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
Operating Profit Margin
Stryker Corp., operating profit margin calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||
| Operating income (loss) | (20) | 635 | 944 | 628 | 613 | 528 | 698 | 576 | 672 | 591 | 712 | 523 | 501 | 554 | 661 | 486 | 500 | 519 | 648 | 378 | 429 | 406 | |||||||
| Net sales | 2,764 | 3,588 | 4,131 | 3,587 | 3,650 | 3,516 | 3,796 | 3,242 | 3,322 | 3,241 | 3,471 | 3,006 | 3,012 | 2,955 | 3,157 | 2,833 | 2,840 | 2,495 | 2,715 | 2,420 | 2,432 | 2,379 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| Operating profit margin1 | 15.54% | 18.86% | 18.23% | 16.96% | 17.00% | 17.83% | 18.65% | 19.22% | 19.16% | 18.28% | 18.40% | 18.46% | 18.42% | 18.68% | 19.13% | 19.78% | 19.53% | 19.62% | 18.71% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| Operating Profit Margin, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 9.23% | 7.91% | 10.18% | 12.98% | 12.37% | 12.63% | 9.37% | 9.29% | 4.69% | 7.32% | 12.22% | 9.29% | 15.17% | 15.21% | 11.46% | 13.23% | 10.22% | 9.60% | 10.45% | 12.53% | 17.60% | 18.59% | |||||||
| Boston Scientific Corp. | 6.58% | 10.41% | 14.14% | 15.66% | 16.19% | 16.50% | 15.33% | 15.57% | 15.74% | 14.33% | 14.20% | 12.53% | 12.36% | 6.04% | 5.33% | 0.44% | -7.68% | -0.76% | -4.37% | — | — | — | |||||||
| Danaher Corp. | 17.37% | 18.01% | 18.25% | 17.46% | 17.61% | 17.41% | 17.11% | 17.27% | 17.23% | 16.69% | 16.48% | 15.73% | 15.69% | 16.09% | 16.29% | 16.51% | 16.27% | 16.81% | 16.87% | — | — | — | |||||||
| Intuitive Surgical Inc. | 25.86% | 30.52% | 30.69% | 30.82% | 31.10% | 30.51% | 32.21% | 33.46% | 33.56% | 34.52% | 33.71% | 33.14% | 33.79% | 34.40% | 34.95% | 35.32% | 33.99% | 32.23% | 31.04% | — | — | — | |||||||
| Medtronic PLC | 20.47% | 21.25% | 20.51% | 20.48% | 20.22% | 21.70% | 22.20% | 21.35% | 20.47% | 18.55% | 17.94% | 17.72% | 18.65% | 18.54% | 18.35% | 14.56% | 15.72% | 16.37% | 18.59% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 17.05% | 17.86% | 17.99% | 17.88% | 18.00% | 15.90% | 15.53% | 15.03% | 14.36% | 14.23% | 14.19% | 13.94% | 13.89% | 13.62% | 13.40% | 13.28% | 13.68% | 13.65% | 13.77% | — | — | — | |||||||
| UnitedHealth Group Inc. | 9.89% | 8.12% | 8.19% | 8.02% | 7.97% | 7.88% | 7.71% | 7.70% | 7.68% | 7.67% | 7.60% | 7.37% | 7.26% | 7.11% | 7.03% | 6.78% | 6.64% | 6.87% | 7.05% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-31), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-06), 10-Q (filing date: 2019-10-30), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-24), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-22), 10-Q (filing date: 2016-04-22), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-10-23), 10-Q (filing date: 2015-07-29), 10-Q (filing date: 2015-04-30).
1 Q2 2020 Calculation
Operating profit margin = 100
× (Operating income (loss)Q2 2020
+ Operating income (loss)Q1 2020
+ Operating income (loss)Q4 2019
+ Operating income (loss)Q3 2019)
÷ (Net salesQ2 2020
+ Net salesQ1 2020
+ Net salesQ4 2019
+ Net salesQ3 2019)
= 100 × (-20 + 635 + 944 + 628)
÷ (2,764 + 3,588 + 4,131 + 3,587)
= 15.54%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Stryker Corp.’s operating profit margin ratio improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
Net Profit Margin
Stryker Corp., net profit margin calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||
| Net earnings (loss) | (83) | 493 | 725 | 466 | 480 | 412 | 2,068 | 590 | 452 | 443 | (249) | 434 | 391 | 444 | 510 | 355 | 380 | 402 | 522 | 301 | 392 | 224 | |||||||
| Net sales | 2,764 | 3,588 | 4,131 | 3,587 | 3,650 | 3,516 | 3,796 | 3,242 | 3,322 | 3,241 | 3,471 | 3,006 | 3,012 | 2,955 | 3,157 | 2,833 | 2,840 | 2,495 | 2,715 | 2,420 | 2,432 | 2,379 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| Net profit margin1 | 11.38% | 14.47% | 13.99% | 23.55% | 24.99% | 25.38% | 26.12% | 9.31% | 8.28% | 8.00% | 8.20% | 14.67% | 14.22% | 14.33% | 14.54% | 15.24% | 15.33% | 16.07% | 14.47% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| Net Profit Margin, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 6.17% | 5.25% | 7.13% | 5.47% | 6.33% | 6.13% | 1.95% | 5.23% | 0.34% | 3.28% | 9.10% | 6.52% | 10.67% | 10.54% | 7.82% | 9.24% | 6.62% | 6.13% | 6.76% | 8.65% | 12.75% | 13.56% | |||||||
| Boston Scientific Corp. | 39.24% | 39.75% | 43.78% | 10.49% | 13.85% | 18.08% | 17.01% | 6.93% | 5.48% | 1.21% | 1.15% | 9.55% | 9.04% | 5.07% | 4.14% | 0.99% | -4.34% | -0.47% | -3.20% | — | — | — | |||||||
| Danaher Corp. | 18.35% | 18.13% | 16.80% | 13.01% | 13.11% | 12.45% | 13.33% | 14.07% | 13.84% | 13.56% | 13.60% | 13.36% | 12.63% | 13.41% | 15.13% | 13.72% | 18.39% | 17.92% | 16.33% | — | — | — | |||||||
| Intuitive Surgical Inc. | 26.07% | 30.11% | 30.80% | 30.94% | 29.95% | 29.78% | 30.29% | 22.31% | 23.20% | 23.25% | 21.09% | 30.16% | 28.44% | 27.99% | 27.21% | 27.51% | 26.80% | 25.67% | 24.69% | — | — | — | |||||||
| Medtronic PLC | 15.11% | 14.41% | 15.16% | 16.10% | 7.44% | 10.56% | 10.36% | 9.44% | 16.93% | 13.75% | 13.56% | 13.51% | 14.62% | 12.70% | 12.27% | 8.52% | 8.92% | 11.28% | 13.20% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 14.12% | 14.31% | 14.47% | 14.24% | 14.24% | 12.89% | 12.06% | 10.75% | 10.36% | 10.24% | 10.64% | 11.74% | 11.80% | 11.58% | 11.06% | 11.10% | 11.35% | 11.49% | 11.64% | — | — | — | |||||||
| UnitedHealth Group Inc. | 6.94% | 5.63% | 5.76% | 5.61% | 5.55% | 5.49% | 5.33% | 5.75% | 5.58% | 5.43% | 5.28% | 4.41% | 4.23% | 4.03% | 3.81% | 3.64% | 3.52% | 3.64% | 3.72% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-31), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-06), 10-Q (filing date: 2019-10-30), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-24), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-22), 10-Q (filing date: 2016-04-22), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-10-23), 10-Q (filing date: 2015-07-29), 10-Q (filing date: 2015-04-30).
1 Q2 2020 Calculation
Net profit margin = 100
× (Net earnings (loss)Q2 2020
+ Net earnings (loss)Q1 2020
+ Net earnings (loss)Q4 2019
+ Net earnings (loss)Q3 2019)
÷ (Net salesQ2 2020
+ Net salesQ1 2020
+ Net salesQ4 2019
+ Net salesQ3 2019)
= 100 × (-83 + 493 + 725 + 466)
÷ (2,764 + 3,588 + 4,131 + 3,587)
= 11.38%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Stryker Corp.’s net profit margin ratio improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
Return on Equity (ROE)
Stryker Corp., ROE calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||
| Net earnings (loss) | (83) | 493 | 725 | 466 | 480 | 412 | 2,068 | 590 | 452 | 443 | (249) | 434 | 391 | 444 | 510 | 355 | 380 | 402 | 522 | 301 | 392 | 224 | |||||||
| Total Stryker shareholders’ equity | 12,754 | 13,115 | 12,807 | 12,315 | 11,943 | 11,693 | 11,730 | 9,860 | 9,460 | 9,214 | 9,966 | 10,425 | 10,035 | 9,704 | 9,550 | 9,332 | 9,098 | 8,808 | 8,511 | 8,484 | 8,505 | 8,321 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| ROE1 | 12.55% | 16.50% | 16.26% | 27.82% | 29.72% | 30.12% | 30.29% | 12.54% | 11.42% | 11.06% | 10.23% | 17.06% | 16.94% | 17.41% | 17.25% | 17.78% | 17.64% | 18.36% | 16.91% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| ROE, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 5.13% | 4.30% | 5.85% | 4.35% | 5.06% | 4.89% | 1.48% | 3.61% | 0.22% | 1.89% | 8.50% | 6.30% | 16.51% | 17.26% | 12.79% | 14.17% | 10.57% | 9.53% | 9.70% | 11.24% | 15.07% | 22.69% | |||||||
| Boston Scientific Corp. | 25.53% | 31.06% | 33.87% | 11.24% | 14.81% | 19.46% | 19.15% | 8.08% | 6.73% | 1.59% | 1.48% | 11.11% | 10.89% | 6.17% | 5.15% | 1.25% | -5.55% | -0.56% | -3.78% | — | — | — | |||||||
| Danaher Corp. | 9.56% | 10.53% | 9.94% | 7.63% | 7.69% | 7.66% | 9.40% | 9.98% | 9.81% | 9.39% | 9.45% | 9.39% | 8.95% | 9.68% | 11.10% | 10.76% | 14.00% | 14.47% | 14.17% | — | — | — | |||||||
| Intuitive Surgical Inc. | 13.00% | 16.30% | 16.69% | 16.93% | 16.65% | 16.33% | 16.89% | 12.68% | 13.68% | 13.97% | 13.97% | 18.21% | 18.05% | 18.88% | 12.74% | 13.03% | 13.09% | 13.22% | 13.63% | — | — | — | |||||||
| Medtronic PLC | 9.23% | 8.78% | 9.25% | 9.87% | 4.56% | 6.30% | 6.12% | 5.59% | 9.75% | 8.12% | 8.01% | 8.03% | 8.45% | 7.18% | 6.80% | 4.79% | 4.43% | 4.97% | 5.03% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 12.41% | 12.85% | 12.45% | 12.24% | 12.33% | 11.46% | 10.65% | 9.55% | 9.05% | 8.62% | 8.76% | 9.42% | 10.12% | 9.96% | 9.39% | 9.21% | 9.39% | 9.52% | 9.25% | — | — | — | |||||||
| UnitedHealth Group Inc. | 26.87% | 24.14% | 24.02% | 24.25% | 24.46% | 24.39% | 23.19% | 25.12% | 24.56% | 23.60% | 22.10% | 19.04% | 18.79% | 18.08% | 18.33% | 17.40% | 16.98% | 17.09% | 17.18% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-31), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-06), 10-Q (filing date: 2019-10-30), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-24), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-22), 10-Q (filing date: 2016-04-22), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-10-23), 10-Q (filing date: 2015-07-29), 10-Q (filing date: 2015-04-30).
1 Q2 2020 Calculation
ROE = 100
× (Net earnings (loss)Q2 2020
+ Net earnings (loss)Q1 2020
+ Net earnings (loss)Q4 2019
+ Net earnings (loss)Q3 2019)
÷ Total Stryker shareholders’ equity
= 100 × (-83 + 493 + 725 + 466)
÷ 12,754 = 12.55%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Stryker Corp.’s ROE improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
Return on Assets (ROA)
Stryker Corp., ROA calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||
| Net earnings (loss) | (83) | 493 | 725 | 466 | 480 | 412 | 2,068 | 590 | 452 | 443 | (249) | 434 | 391 | 444 | 510 | 355 | 380 | 402 | 522 | 301 | 392 | 224 | |||||||
| Total assets | 31,483 | 29,440 | 30,167 | 26,659 | 26,354 | 25,937 | 27,229 | 22,084 | 21,570 | 22,133 | 22,197 | 21,485 | 21,292 | 20,517 | 20,435 | 20,187 | 20,520 | 19,668 | 16,247 | 15,917 | 16,819 | 16,580 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| ROA1 | 5.09% | 7.35% | 6.90% | 12.85% | 13.47% | 13.58% | 13.05% | 5.60% | 5.01% | 4.60% | 4.60% | 8.28% | 7.98% | 8.23% | 8.06% | 8.22% | 7.82% | 8.22% | 8.86% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| ROA, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 2.01% | 1.76% | 2.38% | 1.79% | 2.05% | 1.98% | 0.58% | 1.43% | 0.08% | 0.73% | 2.92% | 2.13% | 5.45% | 5.38% | 3.81% | 4.37% | 3.09% | 2.64% | 2.59% | 3.01% | 3.81% | 6.22% | |||||||
| Boston Scientific Corp. | 12.93% | 14.24% | 15.38% | 4.07% | 5.74% | 7.55% | 7.96% | 3.29% | 2.66% | 0.58% | 0.55% | 4.52% | 4.29% | 2.42% | 1.92% | 0.46% | -1.93% | -0.20% | -1.32% | — | — | — | |||||||
| Danaher Corp. | 4.86% | 4.74% | 4.85% | 4.03% | 4.64% | 4.67% | 5.54% | 5.79% | 5.55% | 5.41% | 5.34% | 5.20% | 4.82% | 5.09% | 5.64% | 6.04% | 6.81% | 7.33% | 6.96% | — | — | — | |||||||
| Intuitive Surgical Inc. | 11.24% | 14.02% | 14.17% | 14.39% | 14.18% | 13.93% | 14.37% | 10.88% | 11.70% | 11.95% | 11.46% | 15.99% | 15.55% | 16.21% | 11.34% | 11.69% | 11.73% | 11.84% | 12.00% | — | — | — | |||||||
| Medtronic PLC | 5.13% | 4.84% | 5.16% | 5.54% | 2.56% | 3.53% | 3.40% | 2.93% | 5.31% | 4.10% | 4.04% | 4.07% | 4.31% | 3.70% | 3.55% | 2.37% | 2.21% | 2.51% | 2.51% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 6.02% | 6.25% | 6.33% | 6.33% | 6.11% | 5.71% | 5.22% | 4.66% | 4.32% | 3.98% | 3.93% | 4.16% | 4.87% | 4.70% | 4.40% | 4.16% | 4.73% | 4.64% | 4.83% | — | — | — | |||||||
| UnitedHealth Group Inc. | 8.88% | 7.27% | 7.96% | 7.68% | 7.77% | 7.83% | 7.87% | 8.32% | 7.67% | 7.21% | 7.59% | 6.14% | 5.87% | 5.53% | 5.71% | 5.30% | 5.17% | 5.10% | 5.22% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-31), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-06), 10-Q (filing date: 2019-10-30), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-24), 10-K (filing date: 2019-02-07), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-08), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-09), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-22), 10-Q (filing date: 2016-04-22), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-10-23), 10-Q (filing date: 2015-07-29), 10-Q (filing date: 2015-04-30).
1 Q2 2020 Calculation
ROA = 100
× (Net earnings (loss)Q2 2020
+ Net earnings (loss)Q1 2020
+ Net earnings (loss)Q4 2019
+ Net earnings (loss)Q3 2019)
÷ Total assets
= 100 × (-83 + 493 + 725 + 466)
÷ 31,483 = 5.09%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Stryker Corp.’s ROA improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |